Open pulmonary tuberculosis has been increasingly seen in HIV-infected patients in this hospice. Multidrug-resistant tuberculosis is a new and serious threat and two cases have occurred in our hospice in the past two years. This infection poses a health risk to staff, patients, relatives and volunteers. Palliative care teams in the hospice and community must have an index of suspicion for this infection, take active measures to ensure patient compliance with tuberculosis treatment and be prepared to implement infection control guidelines when needed.
Barnes PF, Barrows SATuberculosis in the 1990s. Ann Intern Med.1993; 119: 400-10.
2.
Malin AS, McAdam KPEscalating threat form tuberculosis: the third epidemic. Thorax1995; 50 (suppl 1): S37-S42
3.
Churchill DR , Nelson M., Miller RF et al. RisingIncidence of HIV-associated tuberculosis in North London. Thorax1995; 50 (suppl 2): S49.
4.
Small PM, Hopewell PC, Singh SP et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med1994; 330: 1703-709.
5.
Alland D., Kalkut GE, Moss AR et al. Transmission of tuberculosis in New York city. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med1994; 330: 1710-16.
6.
Hamburg MA, Frieden TRTuberculosis transmission in the 1990's. N Engl J Med1994; 330: 1750-51.
7.
Weiss SE, Slocum PC, Blais FX, King B., Nunn M., Matney BGThe effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med1994 ; 330: 1179-83.
8.
Selwyn PA, Harte D., Lewis VA et al. Prospective study of the risk of tuberculosis among intravenous drug-users with human immunodeficiency virus infection. N Engl J Med1989; 320: 545-50.
9.
Small PM, Scheter GF, Goodman PC, Sande MA, Chaisson RE, Hopewell PCTreatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med1991; 324: 289-94.
10.
Schürmann D. , Bergmann F., Jautzke G., Fehrenbach F., Mauch H., Ruf B.Acute and long-term efficacy of antituberculous treatment in HIV-seropositive patients with tuberculosis: a study of 36 cases . J Infect1993; 26: 45-54.
Beck-Sague CB, Dooley SW, Hutton MD et al. Hospital outbreak of multidrug resistant Mycobacterium tuberculosis infections: factors in transmission to staff and HIV infected patients. J Am Med Assoc1992 ; 268: 1280-86.
Saloman N., Perlman D., Friedmann P., Buchstein S., Kreiswirth BN, Mildvan D.Predictors and outcome of multidrug-resistant tuberculosis. Clin Infect Dis1995; 21: 1245-52.
15.
Turett GS, Telzak EE, Torian LV et al. Improved outcomes for patients with multidrug-resistant tuberculosis . Clin Infect Dis1995; 21: 1238-44.
16.
Goble M., Iseman MD, Madesen LA, Waite D., Ackerson L., Horsburgh CRTreatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampicin. N Engl J Med1993; 328: 527-32.
17.
The Interdepartmental Working Group on Tuberculosis.The prevention and control of tuberculosis in the United Kingdom: recommendations for the prevention and control of tuberculosis at local level. London: Department of Health and the Welsh Office, 1996.
18.
Sepkowitz KAHow contagious is tuberculosis ?Clin Infect Dis1996; 23: 954-62.
19.
Bhatti N., Law M.R., Morris J.K., Halliday R., Moore-Gillon J.Increasing incidence of tuberculosis in England and Wales: a study of the likely causes. Br Med J1995; 310: 967-69.
20.
McKeogh MMDementia in palliative disease - a challenge for palliative care?J Palliat Care1995; 11(2): 30-33.
21.
Barnes PF, Block AB, Davidson PT, Snider DETuberculosis in patients with human immunodeficiency virus infection. N Engl J Med1991; 324: 1644-49.
22.
Iseman MDTreatment of multidrug resistant tuberculosis. N Engl J Med1993; 329: 784-91.
23.
Easterbrook P.Multidrug resistant tuberculosis: practical lessons for HIV units. Genitourin Med1996 ;72:313-14.
